Cargando…

Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects

Fluoxetine and other serotonin-specific re-uptake inhibitors (SSRIs) are generally thought to owe their therapeutic potency to inhibition of the serotonin transporter (SERT). However, research in our laboratory showed that it affects, with relatively high affinity the 5-HT(2B) receptor in cultured a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Liang, Gu, Li, Li, Baoman, Hertz, Leif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207076/ https://www.ncbi.nlm.nih.gov/pubmed/25342944 http://dx.doi.org/10.2174/1570159X12666140828221720

Ejemplares similares

Signal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood Disorders
por: Hertz, Leif, et al.
Publicado: (2014)

Chronic SSRI stimulation of astrocytic 5-HT(2B) receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift
por: Hertz, Leif, et al.
Publicado: (2015)

Response: Commentary: Chronic SSRI Stimulation of Astrocytic 5-HT(2B) Receptors Change Multiple Gene Expressions/Editings and Metabolism of Glutamate, Glucose and Glycogen: A Potential Paradigm Shift
por: Hertz, Leif, et al.
Publicado: (2015)

Leptin Increases Expression of 5-HT(2B) Receptors in Astrocytes Thus Enhancing Action of Fluoxetine on the Depressive Behavior Induced by Sleep Deprivation
por: Li, Xiaowei, et al.
Publicado: (2019)

Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation
por: Ungvari, Zoltan, et al.
Publicado: (2019)

Implication of 5-HT7 receptor in prefrontal circuit assembly and detrimental emotional effects of SSRIs during development
por: Olusakin, Jimmy, et al.
Publicado: (2020)

5-HT(4) Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression
por: Amigo, Josep, et al.
Publicado: (2021)

Safety and Efficacy of Drug Holidays for Women with Sexual Dysfunction Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) Other than Fluoxetine: An Open-Label Randomized Clinical Trial
por: Lalegani, Elham, et al.
Publicado: (2023)

5-HT(2C)R blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain
por: Grégoire, Stéphanie, et al.
Publicado: (2013)

Both exogenous 5-HT and endogenous 5-HT, released by fluoxetine, enhance distension evoked propulsion in guinea-pig ileum in vitro
por: Gwynne, Rachel M., et al.
Publicado: (2014)

The effect of chronic fluoxetine administration on anxiety-like behavior and expression of 5-HT-related proteins in rats with constitutively altered 5-HT homeostasis
por: Kesić, Maja, et al.
Publicado: (2012)

Editorial: All 3 Types of Glial Cells Are Important for Memory Formation
por: Hertz, Leif, et al.
Publicado: (2016)

Genetic Background Underlying 5-HT(1A) Receptor Functioning Affects the Response to Fluoxetine
por: Kondaurova, Elena M., et al.
Publicado: (2020)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Biphasic Regulation of Caveolin-1 Gene Expression by Fluoxetine in Astrocytes: Opposite Effects of PI3K/AKT and MAPK/ERK Signaling Pathways on c-fos
por: Li, Baoman, et al.
Publicado: (2017)

Pharmacogenetics of SSRIs and Sexual Dysfunction
por: Osis, Liana, et al.
Publicado: (2010)

Serotonin mediation of early memory formation via 5-HT(2B) receptor-induced glycogenolysis in the day-old chick
por: Gibbs, Marie E., et al.
Publicado: (2014)

Effect of Selective 5-HT6R Agonist on Expression of 5-HT Receptor and Neurotransmitter in Vascular Dementia Rats
por: Yu, Haining, et al.
Publicado: (2017)

Chronic Fluoxetine Impairs the Effects of 5-HT(1A) and 5-HT(2C) Receptors Activation in the PAG and Amygdala on Antinociception Induced by Aversive Situation in Mice
por: Baptista-de-Souza, Daniela, et al.
Publicado: (2020)

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)

Sequential Astrocytic 5-HT(2B) Receptor Stimulation, [Ca(2+)](i) Regulation, Glycogenolysis, Glutamate Synthesis, and K(+) Homeostasis are Similar but Not Identical in Learning and Mood Regulation
por: Chen, Ye, et al.
Publicado: (2016)

Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine
por: Luong, Thu-Lan T., et al.
Publicado: (2022)

The change of gut microbiota in MDD patients under SSRIs treatment
por: Shen, Yang, et al.
Publicado: (2021)

Antidepressants: From MAOIs to SSRIs and more
por: Ramachandraih, Chaitra T., et al.
Publicado: (2011)

Continuing medical education: SSRIs and pregnancy
por: Andrade, Chittaranjan
Publicado: (2010)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

Human 5–HT(4) and 5–HT(7) Receptor Splice Variants: Are they Important?
por: Coupar, Ian M, et al.
Publicado: (2007)

Long and Short Duration Exposures to the Selective Serotonin Reuptake Inhibitors (SSRIs) Fluoxetine, Paroxetine and Sertraline at Environmentally Relevant Concentrations Lead to Adverse Effects on Zebrafish Behaviour and Reproduction
por: Venkatachalam, Ananda Baskaran, et al.
Publicado: (2023)

Temporal variability of glucocorticoid receptor activity is functionally important for the therapeutic action of fluoxetine in the hippocampus
por: Lee, M-S, et al.
Publicado: (2016)

Exploring new frontiers in neuropsychopharmacology: SSRIs for stroke
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2011)

Treatment of 95 post-Covid patients with SSRIs
por: Rus, Carla P., et al.
Publicado: (2023)

Role of the 5-HT(4) receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus
por: Imoto, Yuki, et al.
Publicado: (2015)

A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
por: Yang, Yang, et al.
Publicado: (2021)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

A single channel mutation alters agonist efficacy at 5-HT(3)A and 5-HT(3)AB receptors
por: Thompson, A J, et al.
Publicado: (2013)

FLUOXETINE IN TRICHOTILLOMANIA - A THERAPEUTIC DILEMMA
por: Bhatia, M.S., et al.
Publicado: (1993)

Dibenzofuranylethylamines as 5-HT(2A/2C) Receptor Agonists
por: Yempala, Thirumal, et al.
Publicado: (2020)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

R-Fluoxetine Increases Melanin Synthesis Through a 5-HT1A/2A Receptor and p38 MAPK Signaling Pathways
por: Liu, Li, et al.
Publicado: (2018)

Tryptophan Hydroxylase 2 Deficiency Modifies the Effects of Fluoxetine and Pargyline on the Behavior, 5-HT- and BDNF-Systems in the Brain of Zebrafish (Danio rerio)
por: Evsiukova, Valentina S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pehh5b8kms8jt8e6g6esu1u1rq